Back
Alkermes PLC Vs. Novartis AG Industry Stock Comparison
Sell
43
ALKS
Alkermes PLC
Last Price:
$33.21
Seasonality Move:
0.79%
Sell
47
NVSEF
Novartis AG
Last Price:
$107.20
Seasonality Move:
5.97%
Sell
43
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
-
The current Alkermes PLC [ALKS] share price is $33.21. The Score for ALKS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Novartis AG (NVSEF)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.20. The Score for NVSEF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVSEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $33.21The current trend is moderately bearish and ALKS is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing selling pressure, which indicates risk of future bearish movement.
ALKS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 43.58 | Sell |
Chaikin Money Flow: | -623245 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.73 - 34.97) | Sell |
Bollinger Bands (100): | (28.49 - 33.69) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.52 | Buy |
Relative Strength Index (14 RSI): | 45.11 | Sell |
Chaikin Money Flow: | -708751 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.53 - 115.13) | Sell |
Bollinger Bands (100): | (98.39 - 109.73) | Buy |
ALKS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Sell |
20-day SMA: | 34.21 | Sell |
50-day SMA: | 33.07 | Buy |
200-day SMA: | 28.82 | Buy |
8-day EMA: | 33.83 | Sell |
20-day EMA: | 33.98 | Sell |
50-day EMA: | 33.08 | Buy |
200-day EMA: | 29.9 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.82 | Sell |
20-day SMA: | 111.72 | Sell |
50-day SMA: | 107.39 | Sell |
200-day SMA: | 107.05 | Buy |
8-day EMA: | 110.22 | Sell |
20-day EMA: | 110.51 | Sell |
50-day EMA: | 108.22 | Sell |
200-day EMA: | 105.09 | Buy |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.02 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alkermes PLC Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |